Dose-Proportionality and Intra-Individual Variability of Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate In Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2016
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B; HIV infections
- Focus Pharmacokinetics
- Acronyms HPTN066
- 10 Jun 2017 Biomarkers information updated
- 16 Nov 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 16 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.